Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000345424

Medchemexpress LLC Tovinontrine | 2062661-53-2 | 99.8% | 394.47 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY109193100MG

Encompass_Preferred

Tovinontrine (IMR-687) is described as a highly potent and selective phosphodiesterase-9 (PDE9) inhibitor. It is specifically intended for the treatment of sickle cell disease. The compound exhibits IC50 values of 8.19 nM for PDE9A1 and 9.99 nM for PDE9A2. It is for research use only and not sold to patients.

  • Highly potent and selective PDE9 inhibitor
  • Potential treatment for sickle cell disease
  • Induces hemoglobin (HbF)
  • Increases cGMP levels
  • Reduces sickled red blood cells and hemolysis in vivo

Catalog No. 50-003-45424


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.